Incyte (INCY) Tops Q3 EPS by 17c, Revenues Beat; Raises FY19 Jakafi Revenue Outlook
Go back to Incyte (INCY) Tops Q3 EPS by 17c, Revenues Beat; Raises FY19 Jakafi Revenue Outlook| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 103.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.66 | 52 Week High | $118.49 | |||
| Open | $103.66 | 52 Week Low | $55.00 | |||
| Day High | $103.66 | P/E | N/A | |||
| Day Low | $103.66 | EPS | $-0.56 | |||
| Volume | 608 | |||||
